Stay updated on BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded Naples, Italy, 80131 as a study location; Napoli, Italy, 80131 was removed. Removed the term Interstitial lung disease 2 and the Genetic and Rare Diseases Information Center from the resources.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision: v3.4.3 added and Revision: v3.4.2 removed.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 removed, with no changes to study content or visible data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.0%

- Check65 days agoChange DetectedThe updates are minor UI and metadata changes, including showing the glossary, the Last Update Submitted that Met QC Criteria label, No FEAR Act Data notice, and a Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.